US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

31.445
-1.085-3.34%

Close Dec 30 16:00 ET

31.300
-0.145-0.46%

Post 20:01 ET

4.89BMarket Cap-314.45P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics Q3 2024 Earnings Date

Currency：USDNov 4, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	81.70M	83.88M	+2.17M
Beat Est.	-50.73%	-49.41%	+2.66%
EPS	0.03	0.02	-<0.01
Miss Est.	-96.22%	-97.26%	-27.54%

Analyst Rating

Strong Buy

Dec 30, 2024

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 112.946M	--
--	2024/Q4	-- / 98.260M	--
Nov 4, 2024	2024/Q3	83.879M / 81.705M	--
Aug 6, 2024	2024/Q2	73.466M / 65.893M	--
May 1, 2024	2024/Q1	63.474M / 54.608M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 112.946M--

--2024/Q4-- / 98.260M--

Nov 4, 20242024/Q383.879M / 81.705M--

Aug 6, 20242024/Q273.466M / 65.893M--

May 1, 20242024/Q163.474M / 54.608M--

Unlock Free Earnings Estimates

Open Account

TG Therapeutics Earnings Reports

TG Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:38 ET

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Nov 4 07:24 ET

TG Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 16:12 ET

TG Therapeutics | 10-K/A: Annual report (Amendment)

Aug 9 16:03 ET

Trending US Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS